In this Non-interventional study (NIS) patients with platin-sensitive relapsed ovarian cancer (OC) will be included who are eligible for Niraparib treatment (treatment decision by physician independently before inclusion of the patients into the study). The Niraparib treatment will be according to SmPC. During the NIS study data will be collected at baseline, every 3 months during Niraparib treatment and every 6 months during up to 7 years of follow-up (long term survival) or patient’s death whatever comes first.
In this Non-interventional study (NIS) patients with platin-sensitive relapsed ovarian cancer (OC) will be included who are eligible for Niraparib treatment (treatment decision by physician independently before inclusion of the patients into the study). The Niraparib treatment will be according to SmPC. During the NIS study data will be collected at baseline, every 3 months during Niraparib treatment and every 6 months during up to 7 years of follow-up (long term survival) or patient’s death whatever comes first.
